concept

NEUROTOXICITY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROTOXICITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1195Connections

2Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

NEUROTOXICITY is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, Aging, Als. Connected to 676 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	NEUROTOXICITY
Key Genes/Proteins	ACHE, ACSL4, AGING, AKT, AKT1, ALOX12
Related Diseases	Aging, Als, Alzheimer
Related Pathways	Akt, Alpha-Synuclein

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Quinolinic Acid Neurotoxicity in Neurodegeneration

mechanism · 3699 words

→

Pathway Diagram

graph TD
    NEUROTOXICITY["NEUROTOXICITY"]
    NEUROTOXICITY -->|"activates"| Inflammation["Inflammation"]
    NEUROTOXICITY -->|"activates"| Als["Als"]
    NEUROTOXICITY -->|"activates"| Neuroinflammation["Neuroinflammation"]
    NEUROTOXICITY -->|"inhibits"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
    NEUROTOXICITY -->|"inhibits"| Dementia["Dementia"]
    NEUROTOXICITY -->|"activates"| Parkinson["Parkinson"]
    NEUROTOXICITY -->|"activates"| Ms["Ms"]
    NEUROTOXICITY -->|"activates"| Neurodegeneration["Neurodegeneration"]
    SNCA["SNCA"] -->|"causes"| NEUROTOXICITY
    complement["complement"] -->|"activates"| NEUROTOXICITY
    PI3K_AKT["PI3K-AKT"] -->|"regulates"| NEUROTOXICITY
    catalase_mRNA["catalase mRNA"] -.protects against.-> NEUROTOXICITY
    impaired_autophagic_flux["impaired autophagic flux"] -->|"causes"| NEUROTOXICITY
    P62["P62"] -->|"inhibits"| NEUROTOXICITY
    DDX3X["DDX3X"] -->|"activates"| NEUROTOXICITY
    AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"] -->|"inhibits"| NEUROTOXICITY
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| NEUROTOXICITY
    NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| NEUROTOXICITY

Outgoing (769)

Target	Relation	Type	Str
Als	therapeutic_target	disease	1.00
Autophagy	activates	pathway	1.00
CYTOKINES	activates	gene	1.00
Neurodegeneration	activates	disease	1.00
Als	activates	disease	1.00
Inflammation	activates	disease	1.00
Apoptosis	activates	pathway	1.00
Neurodegeneration	associated_with	disease	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
Neuroinflammation	activates	disease	1.00
APOPTOSIS	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
Oxidative Stress	activates	pathway	1.00
Alzheimer	therapeutic_target	disease	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
Parkinson	therapeutic_target	disease	1.00
Aging	therapeutic_target	disease	1.00
PARKINSON	therapeutic_target	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
Inflammation	therapeutic_target	disease	1.00
ALZHEIMER	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	therapeutic_target	gene	1.00
MICROGLIA	activates	gene	1.00
NEUROINFLAMMATION	activates	gene	1.00
Alzheimer	activates	disease	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
Neurodegeneration	therapeutic_target	disease	1.00
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	1.00
Nf-Κb	activates	pathway	1.00
NEURODEGENERATION	associated_with	gene	1.00
AUTOPHAGY	activates	gene	1.00
Neuroinflammation	therapeutic_target	disease	0.95
NEUROINFLAMMATION	therapeutic_target	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.90
NF-ΚB	activates	gene	0.90
Mtor	activates	pathway	0.90
Ferroptosis	activates	pathway	0.90
TNF-Α	activates	gene	0.90
AMYLOID	activates	gene	0.90
NEURON	activates	gene	0.90
AMPK	activates	gene	0.90
NRF2	activates	gene	0.90
Oxidative Stress	therapeutic_target	pathway	0.90
TAU	activates	gene	0.90
MTOR	activates	gene	0.90
OXIDATIVE STRESS	therapeutic_target	gene	0.90
Cancer	therapeutic_target	disease	0.85
Parkinson	activates	disease	0.85

Incoming (426)

Source	Relation	Type	Str
ROS	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
Nanoparticles	causes	compound	0.95
LiCl	causes	compound	0.95
Sevoflurane	causes	drug	0.95
Methamphetamine	causes	drug	0.95
PKN1-N207	contributes_to	protein	0.90
Oxidative Stress	causes	process	0.90
lithium chloride	causes	drug	0.90
Silver Nanoparticles	causes	compound	0.90
Titanium Dioxide Nanoparticles	causes	compound	0.90
Reactive Astrocytes	mediates	cell_type	0.90
Excitotoxicity	causes	process	0.90
Ion Imbalance	causes	process	0.90
SNCA	causes	gene	0.90
MUTANT SOD1	causes	protein	0.90
AUTOPHAGY	activates	gene	0.90
BPA	causes	drug	0.88
Iron Overload	causes	phenotype	0.88
Gasdermin D	mediates	protein	0.85
Neuroinflammation	contributes_to	process	0.85
Microglia	mediates	cell_type	0.85
mtDNA damage	contributes_to	phenotype	0.85
Beta-Amyloid	causes	protein	0.80
TP53	associated_with	gene	0.80
PLK2	enhances	gene	0.80
Microglia	contributes_to	cell_type	0.80
MITOPHAGY	activates	gene	0.80
APOPTOSIS	therapeutic_target	gene	0.80
MYELIN	activates	gene	0.70
APOPTOSIS	regulates	gene	0.70
KEAP1	activates	gene	0.70
NEURODEGENERATION	causes	gene	0.70
PI3K-AKT	regulates	pathway	0.70
INFLAMMATION	activates	gene	0.70
GSDMD	activates	gene	0.70
Zn	treats	drug	0.70
oligomers	promotes	protein	0.70
ERK	activates	gene	0.70
NLRP3	activates	gene	0.70
TAU	activates	gene	0.70
AUTOPHAGY	regulates	gene	0.70
complement	activates	protein	0.70
impaired autophagic flux	causes	process	0.70
catalase mRNA	protects_against	drug	0.70
NEURODEGENERATION	activates	gene	0.70
autophagy	associated_with	process	0.70
mitophagy	prevents	process	0.70
OXIDATIVE STRESS	activates	gene	0.60
MITOCHONDRIA	activates	gene	0.60

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A	0.710	neuroscience	APOE4-driven lipid metabolism dysregulat
DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxici	0.634	neurodegeneration	Should microtubule-stabilizing drugs be

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning NEUROTOXICITY in their description or question text

No additional research found